2015
DOI: 10.1016/j.lungcan.2015.02.016
|View full text |Cite
|
Sign up to set email alerts
|

Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

8
57
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 76 publications
(67 citation statements)
references
References 25 publications
8
57
2
Order By: Relevance
“…Lee and colleagues [15] suggested that the surgical approach of pGGO with pathological types of AIS and MIA has been recommended for sublobar resection rather than lobectomy. There are also reports [11,16,17] in the literature that multiple GGO patients with surgical resection,the prognosis is satisfactory, even sub-lobectomy does not affect the prognosis. In view of the good prognosis of multiple GGOs [18][19][20], we suggest that sub-lobectomy should be performed as much as possible for patients with multiple GGOs in the same period of surgery, which can ensure the prognosis and make the patient better quality of life.…”
Section: Discussionmentioning
confidence: 95%
“…Lee and colleagues [15] suggested that the surgical approach of pGGO with pathological types of AIS and MIA has been recommended for sublobar resection rather than lobectomy. There are also reports [11,16,17] in the literature that multiple GGO patients with surgical resection,the prognosis is satisfactory, even sub-lobectomy does not affect the prognosis. In view of the good prognosis of multiple GGOs [18][19][20], we suggest that sub-lobectomy should be performed as much as possible for patients with multiple GGOs in the same period of surgery, which can ensure the prognosis and make the patient better quality of life.…”
Section: Discussionmentioning
confidence: 95%
“…The mechanism probably involves the decrease in β-catenin transcription and translation. Cisplatin and any other first-line chemotherapy drug hold the disadvantage of strong toxicity and side effects; non-specificity of drug action is a reason for this phenomenon, thus limiting clinical application33. By contrast, the small-molecule inhibitor BHX targets tumor cells activated by the Wnt signaling pathway but only affects normal cells activated by the same pathway to a lower extent.…”
Section: Discussionmentioning
confidence: 99%
“…Lung adenocarcinomas with ground glass components have been hypothesized to behave less aggressively than solid nodules based on retrospective evidence; however, it has been observed nonetheless that a subset of ground glass-associated malignancies continue to show clinical progression [6,[15][16][17][18]. Our ability to preoperatively identify lesions that aggressively progress is limited.…”
Section: Commentmentioning
confidence: 99%